When.com Web Search

  1. Ads

    related to: jak2 myeloproliferative disorder icd 10

Search results

  1. Results From The WOW.Com Content Network
  2. Myeloproliferative neoplasm - Wikipedia

    en.wikipedia.org/wiki/Myeloproliferative_neoplasm

    The concept of myeloproliferative disease was first proposed in 1951 by the hematologist William Dameshek. [18] The discovery of the association of MPNs with the JAK2 gene marker in 2005 and the CALR marker in 2013 improved the ability to classify MPNs. [19] MPNs were classified as blood cancers by the World Health Organization in 2008. [20]

  3. Janus kinase 2 - Wikipedia

    en.wikipedia.org/wiki/Janus_kinase_2

    Janus kinase 2 (commonly called JAK2) is a non-receptor tyrosine kinase.It is a member of the Janus kinase family and has been implicated in signaling by members of the type II cytokine receptor family (e.g. interferon receptors), the GM-CSF receptor family (IL-3R, IL-5R and GM-CSF-R), the gp130 receptor family (e.g., IL-6R), and the single chain receptors (e.g. Epo-R, Tpo-R, GH-R, PRL-R).

  4. Polycythemia vera - Wikipedia

    en.wikipedia.org/wiki/Polycythemia_vera

    In oncology, polycythemia vera (PV) is an uncommon myeloproliferative neoplasm in which the bone marrow makes too many red blood cells. [1] The majority of cases [2] are caused by mutations in the JAK2 gene, most commonly resulting in a single amino acid change in its protein product from valine to phenylalanine at position 617.

  5. Primary myelofibrosis - Wikipedia

    en.wikipedia.org/wiki/Primary_myelofibrosis

    Primary myelofibrosis (PMF) is a rare bone marrow blood cancer. [1] It is classified by the World Health Organization (WHO) as a type of myeloproliferative neoplasm, a group of cancers in which there is activation and growth of mutated cells in the bone marrow.

  6. Essential thrombocythemia - Wikipedia

    en.wikipedia.org/wiki/Essential_thrombocythemia

    [3] [8] JAK2 is a member of the Janus kinase family. [ 3 ] [ 8 ] In 2013, two groups detected calreticulin mutations in a majority of JAK2 -negative/ MPL -negative patients with essential thrombocythemia and primary myelofibrosis , which makes CALR mutations the second most common in myeloproliferative neoplasms .

  7. Polycythemia - Wikipedia

    en.wikipedia.org/wiki/Polycythemia

    A somatic (non-hereditary) mutation (V617F) in the JAK2 gene, also present in other myeloproliferative disorders, is found in 95% of cases. [21] Symptoms include headaches and vertigo, and signs on physical examination include an abnormally enlarged spleen and/or liver. Studies suggest that mean arterial pressure (MAP) only increases when ...

  1. Ads

    related to: jak2 myeloproliferative disorder icd 10